Stem Pharm: Funding, Investors & Team (Sep 2026)
Stem Pharm was established in 2015 to provide reliable synthetic biomaterials tailored to meet the needs of customers as they enhance their cellular models for drug discovery, toxicity screening, and regenerative medicine applications. Located near the University of Wisconsin campus in the Fitchburg Technology Campus, Stem Pharm utilizes its knowledge of biomaterials and cellular interactions to create valuable organoid models and cell-friendly coatings for cell-based therapy production.
Stem Pharm has raised $80k across 1 funding round on record, the most recent an undisclosed round of $80k announced in Feb 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Stem Pharm Company Profile and Key Stats
Latest funding round on record: Feb 2025.
Stem Pharm Funding Rounds
Stem Pharm Founders and Leadership Team
No contact details are on record for this team yet.
Stem Pharm Funding Compared to Other Biotechnology Startups
Stem Pharm's latest round of $80k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Stem Pharm in Biotechnology and Madison
Companies Similar to Stem Pharm
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Stem Pharm Funding FAQs
What does Stem Pharm do?
Stem Pharm was established in 2015 to provide reliable synthetic biomaterials tailored to meet the needs of customers as they enhance their cellular models for drug discovery, toxicity screening, and regenerative medicine applications. Located near the University of Wisconsin campus in the Fitchburg Technology Campus, Stem Pharm utilizes its knowledge of biomaterials and cellular interactions to create valuable organoid models and cell-friendly coatings for cell-based therapy production.
How much funding has Stem Pharm raised?
Stem Pharm has raised $80k across 1 round on record. The most recent is an undisclosed round of $80k announced in Feb 2025.
When did Stem Pharm last raise funding?
Stem Pharm's most recent funding round on record is an undisclosed round of $80k, announced in Feb 2025.
Who founded Stem Pharm?
FundedIQ lists William L Murphy (Founder) at Stem Pharm.
Where is Stem Pharm headquartered?
Stem Pharm is based in Madison, Wisconsin, United States.
How many employees does Stem Pharm have?
Stem Pharm is in the 1-10 employee band.
How does Stem Pharm's funding compare to other Biotechnology startups?
Stem Pharm's latest round of $80k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Stem Pharm Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Stem Pharm is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.